Trials / Sponsors / 858 Therapeutics, Inc.
858 Therapeutics, Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer | Phase 1 / Phase 2 | 2024-05-13 |